Cytorex Biosciences Completes Cytotoxicity Testing With Its Anti-Cancer Compound Cytoreg®
Posted Wednesday, July 7, 2004
CeeTox was featured in an article by Eworldwire entitled “Cytorex Biosciences Completes Cytotoxicity Testing With Its Anti-Cancer Compound Cytoreg®.”
Testing performed by CeeTox Inc. in rat hepatoma (liver cancer) cells, normal hepatocytes (liver), and normal kidney cells indicate a distinctive cytotoxic activity of Cytoreg® in cancer cells.
